| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.20e-05 | 46 | 130 | 5 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein kinase activity | ABL1 ABL2 RIPK3 ATR PDK3 INSR TRIM24 YES1 RPS6KC1 PRKCZ EIF2AK2 HCK DCLK1 | 1.50e-04 | 600 | 130 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NAGK ABL1 ABL2 RIPK3 ATR PDK3 INSR TRIM24 YES1 RPS6KC1 PRKCZ EIF2AK2 HCK DCLK1 | 2.18e-04 | 709 | 130 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 3.38e-04 | 51 | 130 | 4 | GO:0001784 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.77e-04 | 145 | 130 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | kinase activity | NAGK ABL1 ABL2 RIPK3 ATR PDK3 INSR TRIM24 YES1 RPS6KC1 PRKCZ EIF2AK2 HCK DCLK1 | 4.62e-04 | 764 | 130 | 14 | GO:0016301 |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 ABL1 ABL2 PSD MYCBP2 USP9X PPFIA2 PCLO INSR ADGRL1 ALS2 IQSEC1 ROBO2 TANC1 NRG3 DCLK1 | 8.91e-06 | 685 | 133 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | brain development | DMXL2 PDSS2 ABL1 ABL2 USP9X ANXA3 SRF CCDC141 DICER1 ROBO2 KDM7A NRG3 PCDH9 HYDIN TCTN1 DCLK1 MYO16 | 3.86e-05 | 859 | 133 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | TANC2 ABL1 PSD MYCBP2 USP9X PPFIA2 ADGRL1 IQSEC1 ROBO2 TANC1 DCLK1 | 4.30e-05 | 387 | 133 | 11 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | TANC2 ABL1 PSD MYCBP2 USP9X PPFIA2 ADGRL1 IQSEC1 ROBO2 TANC1 DCLK1 | 5.17e-05 | 395 | 133 | 11 | GO:0050803 |
| GeneOntologyBiologicalProcess | central nervous system development | DMXL2 PDSS2 ABL1 ABL2 MYCBP2 USP9X ANXA3 SRF GCM1 DCC CCDC141 DICER1 ROBO2 KDM7A NRG3 PCDH9 HYDIN TCTN1 DCLK1 MYO16 | 8.30e-05 | 1197 | 133 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | head development | DMXL2 PDSS2 ABL1 ABL2 USP9X ANXA3 SRF CCDC141 DICER1 ROBO2 KDM7A NRG3 PCDH9 HYDIN TCTN1 DCLK1 MYO16 | 8.87e-05 | 919 | 133 | 17 | GO:0060322 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 SETX ABL1 ABL2 PSD MYCBP2 MYO7A USP9X PPFIA2 FAT3 SRF ALS2 DCC DICER1 UGDH IQSEC1 TENM1 ROBO2 PRKCZ TCTN1 DCLK1 MYO16 | 1.64e-04 | 1463 | 133 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 1.68e-04 | 43 | 133 | 4 | GO:0021955 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.77e-04 | 308 | 133 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 ABL1 ABL2 PSD MYCBP2 USP9X PPFIA2 PCLO INSR SRF ADGRL1 ALS2 IQSEC1 ROBO2 TANC1 NRG3 DCLK1 | 1.78e-04 | 974 | 133 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 ABL1 ABL2 MYCBP2 USP9X PPFIA2 SRF ALS2 DCC DICER1 ROBO2 PRKCZ TCTN1 DCLK1 MYO16 | 2.10e-04 | 802 | 133 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 SETX ABL1 ABL2 PSD MYCBP2 MYO7A USP9X PPFIA2 FAT3 SRF ALS2 DCC DICER1 IQSEC1 ROBO2 PRKCZ TCTN1 DCLK1 MYO16 | 2.15e-04 | 1285 | 133 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CAND1 ABL1 PSD ATR MYCBP2 USP9X ZDHHC5 SRF ADGRL1 FHOD3 FNBP1L IQSEC1 TENM1 SYP ROBO2 PRKCZ EIF2AK2 HCK DCLK1 | 2.25e-04 | 1189 | 133 | 19 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 KLHL10 ABL1 ABL2 MYCBP2 MYO7A USP9X PPFIA2 FAT3 SRF ALS2 DCC DICER1 ROBO2 PRKCZ HCK TCTN1 DCLK1 MYO16 | 2.38e-04 | 1194 | 133 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 2.46e-04 | 4 | 133 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 2.46e-04 | 4 | 133 | 2 | GO:1903905 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 ABL1 ABL2 MYCBP2 USP9X PPFIA2 SRF ALS2 DCC DICER1 ROBO2 PRKCZ TCTN1 DCLK1 MYO16 | 2.63e-04 | 819 | 133 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 ABL1 ABL2 MYCBP2 USP9X PPFIA2 SRF ALS2 DCC DICER1 ROBO2 PRKCZ TCTN1 DCLK1 MYO16 | 2.88e-04 | 826 | 133 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 3.08e-04 | 91 | 133 | 5 | GO:2000142 | |
| GeneOntologyBiologicalProcess | telencephalon development | 3.09e-04 | 332 | 133 | 9 | GO:0021537 | |
| GeneOntologyBiologicalProcess | forebrain development | DMXL2 USP9X ANXA3 SRF CCDC141 DICER1 ROBO2 NRG3 PCDH9 TCTN1 DCLK1 | 3.33e-04 | 489 | 133 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 3.42e-04 | 202 | 133 | 7 | GO:0051963 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ABL1 ABL2 MYCBP2 MYO7A USP9X PPFIA2 FAT3 SRF ALS2 DCC ROBO2 TCTN1 DCLK1 | 3.43e-04 | 748 | 133 | 14 | GO:0048667 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.39e-09 | 56 | 133 | 8 | GO:0099091 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 PSD PPFIA2 PCLO ZDHHC5 ALS2 DCC YES1 DICER1 RPS6KC1 IQSEC1 SYP SORCS3 ROBO2 DLG3 TANC1 PRKCZ DCLK1 | 3.34e-09 | 503 | 133 | 18 | GO:0099572 |
| GeneOntologyCellularComponent | axon | TANC2 PDE2A SETX ABL1 MYCBP2 USP9X ANXA3 PPFIA2 PCLO INSR ADGRL1 ALS2 DCC DICER1 OPTN SYP ROBO2 DLG3 TANC1 PRKCZ PCDH9 DCLK1 | 4.63e-08 | 891 | 133 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 PSD PCLO ALS2 DCC DICER1 RPS6KC1 IQSEC1 SYP SORCS3 ROBO2 DLG3 TANC1 PRKCZ DCLK1 | 1.92e-07 | 451 | 133 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 PSD PCLO ALS2 DCC DICER1 RPS6KC1 IQSEC1 SYP SORCS3 ROBO2 DLG3 TANC1 PRKCZ DCLK1 | 3.93e-07 | 477 | 133 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | postsynapse | TANC2 ABL1 ABL2 PSD ATR USP9X PPFIA2 PCLO ZDHHC5 ALS2 DCC YES1 DICER1 RPS6KC1 IQSEC1 SYP SORCS3 ROBO2 DLG3 TANC1 PRKCZ DCLK1 | 4.60e-07 | 1018 | 133 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | growth cone | SETX ABL1 USP9X PCLO ADGRL1 ALS2 DCC DICER1 DLG3 PCDH9 DCLK1 | 4.92e-07 | 245 | 133 | 11 | GO:0030426 |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 6.62e-07 | 49 | 133 | 6 | GO:0099092 | |
| GeneOntologyCellularComponent | site of polarized growth | SETX ABL1 USP9X PCLO ADGRL1 ALS2 DCC DICER1 DLG3 PCDH9 DCLK1 | 6.75e-07 | 253 | 133 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 PSD PCLO ALS2 DCC DICER1 RPS6KC1 IQSEC1 SYP SORCS3 ROBO2 DLG3 TANC1 PRKCZ DCLK1 | 1.25e-06 | 523 | 133 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | distal axon | SETX ABL1 USP9X PCLO ADGRL1 ALS2 DCC DICER1 SYP DLG3 TANC1 PCDH9 DCLK1 | 4.27e-06 | 435 | 133 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 ABL2 PPFIA2 PCLO ZDHHC5 ADGRL1 ALS2 YES1 DICER1 IQSEC1 SORCS3 ROBO2 DLG3 TANC1 PRKCZ NRG3 DCLK1 | 1.73e-05 | 817 | 133 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | dendrite | TANC2 PDE2A ABL1 ABL2 PSD CLIP2 ANXA3 PPFIA2 FAT3 PCLO INSR ZDHHC5 ALS2 DICER1 DLG3 TANC1 | 1.13e-04 | 858 | 133 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 PDE2A ABL1 ABL2 PSD CLIP2 ANXA3 PPFIA2 FAT3 PCLO INSR ZDHHC5 ALS2 DICER1 DLG3 TANC1 | 1.17e-04 | 860 | 133 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 PDE2A ABL1 ABL2 PSD CLIP2 ANXA3 PPFIA2 FAT3 PCLO INSR ZDHHC5 ALS2 APOB DICER1 OPTN DLG3 TANC1 PRKCZ | 2.86e-04 | 1228 | 133 | 19 | GO:0036477 |
| Domain | F_actin_bind | 4.37e-05 | 2 | 124 | 2 | PF08919 | |
| Domain | F-actin_binding | 4.37e-05 | 2 | 124 | 2 | IPR015015 | |
| Domain | FABD | 4.37e-05 | 2 | 124 | 2 | SM00808 | |
| Domain | SH3 | 9.81e-05 | 216 | 124 | 8 | SM00326 | |
| Domain | SH3 | 9.81e-05 | 216 | 124 | 8 | PS50002 | |
| Domain | SH3_domain | 1.11e-04 | 220 | 124 | 8 | IPR001452 | |
| Domain | SH3_1 | 1.13e-04 | 164 | 124 | 7 | PF00018 | |
| Domain | - | 1.23e-04 | 15 | 124 | 3 | 3.30.70.960 | |
| Domain | Vitellinogen_superhlx | 1.31e-04 | 3 | 124 | 2 | IPR011030 | |
| Domain | Tyr_kinase_cat_dom | 3.00e-04 | 88 | 124 | 5 | IPR020635 | |
| Domain | TyrKc | 3.00e-04 | 88 | 124 | 5 | SM00219 | |
| Domain | SEA | 4.01e-04 | 22 | 124 | 3 | PF01390 | |
| Domain | WHIM1_dom | 4.32e-04 | 5 | 124 | 2 | IPR028942 | |
| Domain | WHIM1 | 4.32e-04 | 5 | 124 | 2 | PF15612 | |
| Domain | SEA | 4.59e-04 | 23 | 124 | 3 | PS50024 | |
| Domain | SEA_dom | 4.59e-04 | 23 | 124 | 3 | IPR000082 | |
| Domain | PROTEIN_KINASE_TYR | 4.71e-04 | 97 | 124 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.71e-04 | 97 | 124 | 5 | IPR008266 | |
| Domain | SH2 | 5.67e-04 | 101 | 124 | 5 | PF00017 | |
| Domain | DDT | 6.45e-04 | 6 | 124 | 2 | PS50827 | |
| Domain | SH2 | 8.35e-04 | 110 | 124 | 5 | SM00252 | |
| Domain | SH2 | 8.70e-04 | 111 | 124 | 5 | PS50001 | |
| Domain | SH2 | 9.06e-04 | 112 | 124 | 5 | IPR000980 | |
| Domain | - | 9.06e-04 | 112 | 124 | 5 | 3.30.505.10 | |
| Domain | Zinc_finger_PHD-type_CS | 9.17e-04 | 65 | 124 | 4 | IPR019786 | |
| Domain | Protein_kinase_ATP_BS | 9.69e-04 | 379 | 124 | 9 | IPR017441 | |
| Domain | Kinase-like_dom | ABL1 ABL2 RIPK3 ATR INSR YES1 RPS6KC1 PRKCZ EIF2AK2 HCK DCLK1 | 9.78e-04 | 542 | 124 | 11 | IPR011009 |
| Domain | PROTEIN_KINASE_ATP | 9.81e-04 | 459 | 124 | 10 | PS00107 | |
| Domain | PHD | 1.56e-03 | 75 | 124 | 4 | PF00628 | |
| Domain | Prot_kinase_dom | 1.57e-03 | 489 | 124 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.67e-03 | 493 | 124 | 10 | PS50011 | |
| Domain | Pkinase_Tyr | 1.70e-03 | 129 | 124 | 5 | PF07714 | |
| Domain | Znf_PHD-finger | 1.89e-03 | 79 | 124 | 4 | IPR019787 | |
| Domain | CAP_GLY | 1.90e-03 | 10 | 124 | 2 | PF01302 | |
| Domain | CAP_GLY | 1.90e-03 | 10 | 124 | 2 | SM01052 | |
| Domain | - | 1.90e-03 | 10 | 124 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 1.90e-03 | 10 | 124 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.90e-03 | 10 | 124 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.90e-03 | 10 | 124 | 2 | IPR000938 | |
| Domain | EMI | 1.90e-03 | 10 | 124 | 2 | PF07546 | |
| Domain | ARM-like | 2.19e-03 | 270 | 124 | 7 | IPR011989 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.28e-03 | 138 | 124 | 5 | IPR001245 | |
| Domain | PHD | 2.93e-03 | 89 | 124 | 4 | SM00249 | |
| Domain | Znf_FYVE_PHD | 3.00e-03 | 147 | 124 | 5 | IPR011011 | |
| Domain | Znf_PHD | 3.17e-03 | 91 | 124 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 3.70e-03 | 95 | 124 | 4 | PS50016 | |
| Domain | SEA | 3.78e-03 | 14 | 124 | 2 | SM00200 | |
| Domain | ZF_PHD_1 | 3.84e-03 | 96 | 124 | 4 | PS01359 | |
| Domain | - | 4.34e-03 | 15 | 124 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 4.34e-03 | 15 | 124 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.34e-03 | 15 | 124 | 2 | IPR023394 | |
| Domain | EMI_domain | 4.94e-03 | 16 | 124 | 2 | IPR011489 | |
| Domain | SEC7 | 4.94e-03 | 16 | 124 | 2 | PS50190 | |
| Domain | Sec7 | 4.94e-03 | 16 | 124 | 2 | SM00222 | |
| Domain | Sec7_dom | 4.94e-03 | 16 | 124 | 2 | IPR000904 | |
| Domain | EMI | 5.57e-03 | 17 | 124 | 2 | PS51041 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 6.96e-06 | 41 | 93 | 5 | M159 | |
| Pubmed | TANC2 DMXL2 ABL2 CLIP2 MYCBP2 PPFIA2 PCLO ZDHHC5 ADGRL1 FNBP1L IQSEC1 DCLK1 | 1.24e-08 | 347 | 135 | 12 | 17114649 | |
| Pubmed | Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. | 5.72e-08 | 3 | 135 | 3 | 12748290 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 AMER1 CAND1 MYCBP2 NEIL1 PPFIA2 INSR HECTD4 SRF ADGRL1 FNBP1L HIVEP3 PLPP1 SUPT6H KCNJ3 EHF CDYL2 TANC1 PRKCZ NRG3 TET3 ZC3HAV1 | 7.00e-08 | 1489 | 135 | 22 | 28611215 |
| Pubmed | Essential roles for the Abl and Arg tyrosine kinases in neurulation. | 5.69e-07 | 5 | 135 | 3 | 9883720 | |
| Pubmed | TANC2 DMXL2 PDE2A LIMA1 CAND1 CLIP2 MYO7A USP9X PPFIA2 PCLO MTMR1 ADGRL1 IQSEC1 SYP DLG3 TANC1 UQCRFS1 HCK DCLK1 UQCRFS1P1 | 7.05e-07 | 1431 | 135 | 20 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 LIMA1 AMER1 SETX ABL1 ABL2 MYCBP2 ALS2 CEP350 OPTN STARD9 IQSEC1 TANC1 DCLK1 ZC3HAV1 | 1.39e-06 | 861 | 135 | 15 | 36931259 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.66e-06 | 281 | 135 | 9 | 28706196 | |
| Pubmed | 1.84e-06 | 147 | 135 | 7 | 16959763 | ||
| Pubmed | AMER1 SETX CAND1 INSR NUP98 ZDHHC5 MUC16 APOB CEP350 UGDH DLG3 TOR1AIP1 PCDH9 ZC3HAV1 | 2.17e-06 | 777 | 135 | 14 | 35844135 | |
| Pubmed | 2.17e-06 | 24 | 135 | 4 | 20624904 | ||
| Pubmed | MON2 TANC2 DMXL2 MYCBP2 PDK3 USP9X PPFIA2 PCLO ATG2B ADGRL1 RPS6KC1 KCNJ3 IQSEC1 TENM1 SYP DLG3 DCLK1 | 2.18e-06 | 1139 | 135 | 17 | 36417873 | |
| Pubmed | 2.70e-06 | 100 | 135 | 6 | 10048485 | ||
| Pubmed | FLG LIMA1 AMER1 RPN2 PPFIA2 PCLO RSF1 NUP98 APOB FNBP1L DCC RPS6KC1 DNAJC10 BAZ1A STARD9 TENM1 DLG3 TMPRSS7 BAHCC1 | 3.25e-06 | 1442 | 135 | 19 | 35575683 | |
| Pubmed | TANC2 DMXL2 CMTR1 CLIP2 ZDHHC5 ZFP28 CEP350 HIVEP3 PWWP2A ADGRF5 REXO1L1P | 3.84e-06 | 493 | 135 | 11 | 15368895 | |
| Pubmed | 4.13e-06 | 28 | 135 | 4 | 18067320 | ||
| Pubmed | MON2 DNAJB12 AMER1 CAND1 MYCBP2 ATG2B RHBDD2 DNAJC10 IQSEC1 UQCRFS1 UQCRFS1P1 ZC3HAV1 | 4.65e-06 | 606 | 135 | 12 | 36538041 | |
| Pubmed | Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. | 4.72e-06 | 9 | 135 | 3 | 25624478 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 5.01e-06 | 171 | 135 | 7 | 20201926 | |
| Pubmed | 6.23e-06 | 421 | 135 | 10 | 36976175 | ||
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 18155796 | ||
| Pubmed | 7.18e-06 | 32 | 135 | 4 | 22974441 | ||
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 31045206 | ||
| Pubmed | 9.94e-06 | 73 | 135 | 5 | 24728074 | ||
| Pubmed | 1.26e-05 | 197 | 135 | 7 | 36604605 | ||
| Pubmed | 1.29e-05 | 77 | 135 | 5 | 22973453 | ||
| Pubmed | Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion. | 1.50e-05 | 2 | 135 | 2 | 30635569 | |
| Pubmed | Functional interaction between nuclear matrix-associated HBXAP and NF-kappaB. | 1.50e-05 | 2 | 135 | 2 | 15242768 | |
| Pubmed | Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. | 1.50e-05 | 2 | 135 | 2 | 15987940 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23415911 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22028811 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22665498 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12220663 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23399035 | ||
| Pubmed | Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. | 1.50e-05 | 2 | 135 | 2 | 11279004 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 34498705 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28112683 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17686996 | ||
| Pubmed | ABL tyrosine kinases: evolution of function, regulation, and specificity. | 1.50e-05 | 2 | 135 | 2 | 20841568 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20482842 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26485751 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20181660 | ||
| Pubmed | Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus. | 1.50e-05 | 2 | 135 | 2 | 20181697 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26918940 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24088304 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2108863 | ||
| Pubmed | TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis. | 1.50e-05 | 2 | 135 | 2 | 32895234 | |
| Pubmed | c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. | 1.50e-05 | 2 | 135 | 2 | 20150913 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8088805 | ||
| Pubmed | Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases. | 1.50e-05 | 2 | 135 | 2 | 28555614 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22106410 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19805386 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21892207 | ||
| Pubmed | Optineurin suppression causes neuronal cell death via NF-κB pathway. | 1.50e-05 | 2 | 135 | 2 | 23721573 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21338484 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18401429 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 33122628 | ||
| Pubmed | Role of microRNA processing in adipose tissue in stress defense and longevity. | 1.50e-05 | 2 | 135 | 2 | 22958919 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23525682 | ||
| Pubmed | Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity. | 1.50e-05 | 2 | 135 | 2 | 12626632 | |
| Pubmed | Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species. | 1.50e-05 | 2 | 135 | 2 | 19506089 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21068316 | ||
| Pubmed | The Abl family kinases: mechanisms of regulation and signaling. | 1.50e-05 | 2 | 135 | 2 | 12374288 | |
| Pubmed | Defective T cell development and function in the absence of Abelson kinases. | 1.50e-05 | 2 | 135 | 2 | 18025176 | |
| Pubmed | SETX CAND1 RSF1 NUP98 ZNF831 CCDC141 BAZ1A SUPT6H NFKB1 HYDIN | 1.59e-05 | 469 | 135 | 10 | 27634302 | |
| Pubmed | 1.86e-05 | 83 | 135 | 5 | 23568457 | ||
| Pubmed | NOVA2-mediated RNA regulation is required for axonal pathfinding during development. | 2.02e-05 | 14 | 135 | 3 | 27223325 | |
| Pubmed | 2.52e-05 | 15 | 135 | 3 | 25036101 | ||
| Pubmed | 3.09e-05 | 16 | 135 | 3 | 11071635 | ||
| Pubmed | Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo. | 4.48e-05 | 3 | 135 | 2 | 30815534 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 19357831 | ||
| Pubmed | Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages. | 4.48e-05 | 3 | 135 | 2 | 23100514 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23149623 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22738912 | ||
| Pubmed | Tanc1/2 TPR domain interacts with Myo18a C-terminus and undergoes liquid-liquid phase separation. | 4.48e-05 | 3 | 135 | 2 | 38092135 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 10849448 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23328522 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17114179 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 9211900 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 15069075 | ||
| Pubmed | Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress. | 4.48e-05 | 3 | 135 | 2 | 15735735 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 30021165 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 26202421 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22350415 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 12569093 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22914734 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23266528 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 22733220 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18794796 | ||
| Pubmed | Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta. | 4.48e-05 | 3 | 135 | 2 | 19563810 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 9774693 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 25691660 | ||
| Pubmed | Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. | 4.48e-05 | 3 | 135 | 2 | 12777400 | |
| Pubmed | USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly. | 4.48e-05 | 3 | 135 | 2 | 20339350 | |
| Pubmed | Netrin-1 promotes glioma growth by activating NF-κB via UNC5A. | 4.48e-05 | 3 | 135 | 2 | 28710382 | |
| Pubmed | Postnatal DNA demethylation and its role in tissue maturation. | 4.48e-05 | 3 | 135 | 2 | 29795194 | |
| Pubmed | Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma. | 4.48e-05 | 3 | 135 | 2 | 31352437 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 16631755 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 30595481 | ||
| Pubmed | Arg kinase regulates prefrontal dendritic spine refinement and cocaine-induced plasticity. | 4.48e-05 | 3 | 135 | 2 | 22396406 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28820388 | ||
| Interaction | DLG4 interactions | TANC2 PDE2A CAND1 ZDHHC5 MTMR1 ADGRL1 ALS2 FNBP1L DCC YES1 IQSEC1 DLG3 TANC1 | 6.33e-06 | 449 | 129 | 13 | int:DLG4 |
| Interaction | PDIA6 interactions | DNAJB12 DPP4 CAND1 MYCBP2 INSR ATG2B TRIM24 DNAJC10 UGDH PRKCZ TCTN1 | 8.42e-06 | 327 | 129 | 11 | int:PDIA6 |
| Interaction | HSP90B1 interactions | DNAJB12 DPP4 DMXL2 CAND1 RPN2 INSR APOB FNBP1L ITGAD TRIM24 DNAJC10 SUPT6H CDYL2 PRKCZ TCTN1 | 1.81e-05 | 650 | 129 | 15 | int:HSP90B1 |
| Cytoband | 5q11 | 2.57e-05 | 3 | 135 | 2 | 5q11 | |
| Cytoband | 20q12-q13.1 | 3.80e-04 | 10 | 135 | 2 | 20q12-q13.1 | |
| GeneFamily | SH2 domain containing | 1.49e-04 | 101 | 90 | 5 | 741 | |
| GeneFamily | EMI domain containing | 5.06e-04 | 7 | 90 | 2 | 540 | |
| GeneFamily | PHD finger proteins | 1.06e-03 | 90 | 90 | 4 | 88 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 PSD MYCBP2 MYO7A PPFIA2 PCLO LYSMD2 ADGRL1 FHOD3 FNBP1L MED13L DCC CCDC141 DICER1 HIVEP3 OPTN TENM1 SYP SORCS3 ROBO2 DLG3 PRKCZ PCDH9 HYDIN DCLK1 | 3.03e-10 | 1106 | 133 | 25 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | PSD DSC3 MYCBP2 NEIL1 PPFIA2 PCLO FHOD3 FNBP1L DICER1 OPTN TENM1 SYP SORCS3 ROBO2 PCDH9 DCLK1 | 5.89e-07 | 703 | 133 | 16 | M39070 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | LIMA1 ANXA3 RIPOR3 FNBP1L RPS6KC1 OPTN KCNJ3 CDYL2 DMRTA1 KDM7A PCDH9 DCLK1 GAREM1 | 1.85e-06 | 504 | 133 | 13 | M2157 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DPP4 CWF19L2 LIMA1 SETX ATR MYCBP2 USP9X RSF1 TRIM24 RPS6KC1 CEP350 OPTN BAZ1A GAREM1 | 6.52e-06 | 656 | 133 | 14 | M18979 |
| Coexpression | GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN | 7.76e-06 | 197 | 133 | 8 | M7696 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_DC_DN | 8.05e-06 | 198 | 133 | 8 | M4701 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | PDE2A PSD PCLO INSR LYSMD2 ADGRL1 MMRN1 OPTN IQSEC1 SYP ROBO2 | 1.25e-05 | 429 | 133 | 11 | M45694 |
| Coexpression | TBK1.DF_DN | 1.62e-05 | 286 | 133 | 9 | M2864 | |
| Coexpression | FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN | 2.90e-05 | 70 | 133 | 5 | M5370 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN | 4.46e-05 | 14 | 133 | 3 | M34015 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 5.55e-05 | 335 | 133 | 9 | M39065 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 7.26e-05 | 199 | 133 | 7 | M9523 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 7.49e-05 | 200 | 133 | 7 | M8967 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 1.07e-04 | 147 | 133 | 6 | MM414 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 SETX CAND1 ATR MYCBP2 USP9X NUP98 FNBP1L MED13L TRIM24 DICER1 CEP350 BAZ1A NFKB1 | 1.19e-04 | 856 | 133 | 14 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CWF19L2 NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 BAZ1A IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 | 7.34e-09 | 688 | 130 | 20 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | NAGK USP9X PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 | 2.02e-08 | 658 | 130 | 19 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 KDM7A NRG3 PCDH9 TCTN1 MOCS2 | 2.89e-08 | 747 | 130 | 20 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 BAZ1A IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 MOCS2 | 2.89e-08 | 747 | 130 | 20 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | NAGK PPFIA2 FAT3 PCLO INSR MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 BAZ1A IQSEC1 SYP SORCS3 KDM7A NRG3 PCDH9 TCTN1 | 3.65e-08 | 683 | 130 | 19 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 MOCS2 | 8.52e-08 | 721 | 130 | 19 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 STARD9 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 | 1.08e-07 | 732 | 130 | 19 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 MOCS2 | 1.36e-07 | 743 | 130 | 19 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 | 4.34e-07 | 722 | 130 | 18 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 ADGRL1 FHOD3 DCC SLC5A2 CEP350 IQSEC1 SYP SORCS3 NRG3 PCDH9 TCTN1 | 5.09e-07 | 730 | 130 | 18 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 FHOD3 DCC SLC5A2 CEP350 SYP SORCS3 NRG3 PCDH9 TCTN1 | 1.13e-06 | 614 | 130 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | NAGK PPFIA2 FAT3 PCLO INSR HECTD4 MTMR1 DCC SLC5A2 CEP350 BAZ1A SYP SORCS3 NRG3 PCDH9 TCTN1 | 2.82e-06 | 659 | 130 | 16 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | ARHGAP42 DPP4 CAND1 MYCBP2 USP9X INSR MTMR1 FHOD3 CEP350 EHF SORCS3 EIF2AK2 | 6.95e-06 | 402 | 130 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | CWF19L2 NAGK PPFIA2 FAT3 PCLO INSR MTMR1 FHOD3 DCC YES1 SLC5A2 CEP350 SYP SORCS3 KDM7A NRG3 PCDH9 TCTN1 | 8.65e-06 | 893 | 130 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.04e-05 | 91 | 130 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.40e-05 | 201 | 130 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | ARHGAP42 DPP4 CAND1 MYCBP2 USP9X INSR MTMR1 FHOD3 CCDC141 CEP350 EHF SORCS3 ROBO2 EIF2AK2 DCLK1 | 1.08e-04 | 795 | 130 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ARHGAP42 MYCBP2 USP9X INSR MTMR1 CCDC141 CEP350 EHF EIF2AK2 DCLK1 | 1.16e-04 | 379 | 130 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.32e-04 | 385 | 130 | 10 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.32e-04 | 312 | 130 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.65e-04 | 45 | 130 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | ARHGAP42 AMER1 USP9X FAT3 MUC16 TRIM24 CCDC141 AXIN2 CEP350 UGDH DMRTA1 BACE2 PCDH9 DCLK1 | 1.80e-04 | 740 | 130 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.95e-04 | 194 | 130 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | PDE2A SETX MYCBP2 MYO7A ANXA3 ZFP28 YES1 MMRN1 HIVEP3 PLPP1 BAZ1A ADGRF5 HCK ZC3HAV1 | 2.50e-04 | 764 | 130 | 14 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | PDE2A MYO7A ANXA3 YES1 MMRN1 HIVEP3 PLPP1 ADGRF5 HCK ZC3HAV1 | 3.21e-04 | 430 | 130 | 10 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 3.35e-04 | 54 | 130 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_500 | 4.16e-04 | 157 | 130 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k2 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 6.25e-09 | 189 | 134 | 9 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-08 | 181 | 134 | 8 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-08 | 184 | 134 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-08 | 184 | 134 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-08 | 184 | 134 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 9.80e-08 | 186 | 134 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.11e-07 | 189 | 134 | 8 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.20e-07 | 191 | 134 | 8 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.20e-07 | 191 | 134 | 8 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.25e-07 | 192 | 134 | 8 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-07 | 192 | 134 | 8 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-07 | 192 | 134 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.65e-07 | 199 | 134 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-07 | 200 | 134 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-07 | 200 | 134 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 8.52e-07 | 170 | 134 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-06 | 180 | 134 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-06 | 181 | 134 | 7 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 183 | 134 | 7 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 183 | 134 | 7 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 184 | 134 | 7 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.45e-06 | 184 | 134 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.55e-06 | 186 | 134 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.55e-06 | 186 | 134 | 7 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 188 | 134 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.79e-06 | 190 | 134 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.85e-06 | 191 | 134 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 192 | 134 | 7 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 192 | 134 | 7 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 192 | 134 | 7 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.92e-06 | 192 | 134 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.99e-06 | 193 | 134 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 193 | 134 | 7 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-06 | 194 | 134 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-06 | 194 | 134 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 2.06e-06 | 194 | 134 | 7 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.20e-06 | 196 | 134 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.35e-06 | 198 | 134 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-06 | 198 | 134 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 6.04e-06 | 149 | 134 | 6 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.41e-06 | 161 | 134 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 162 | 134 | 6 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 163 | 134 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 173 | 134 | 6 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 175 | 134 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-05 | 178 | 134 | 6 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.72e-05 | 179 | 134 | 6 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.72e-05 | 179 | 134 | 6 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 180 | 134 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 181 | 134 | 6 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 181 | 134 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.83e-05 | 181 | 134 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 182 | 134 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.89e-05 | 182 | 134 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.89e-05 | 182 | 134 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.95e-05 | 183 | 134 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 1.95e-05 | 183 | 134 | 6 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 134 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.95e-05 | 183 | 134 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.01e-05 | 184 | 134 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.01e-05 | 184 | 134 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.07e-05 | 185 | 134 | 6 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 185 | 134 | 6 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 185 | 134 | 6 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.13e-05 | 186 | 134 | 6 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.13e-05 | 186 | 134 | 6 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 187 | 134 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.20e-05 | 187 | 134 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 187 | 134 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 188 | 134 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 188 | 134 | 6 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.26e-05 | 188 | 134 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 190 | 134 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 190 | 134 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 190 | 134 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 190 | 134 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 190 | 134 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.40e-05 | 190 | 134 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 190 | 134 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.47e-05 | 191 | 134 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 191 | 134 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-05 | 191 | 134 | 6 | 13460059a0c1ed9f476cef28b8ad4c06349056c6 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 191 | 134 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.47e-05 | 191 | 134 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 191 | 134 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 191 | 134 | 6 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.55e-05 | 192 | 134 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| Disease | Amyotrophic lateral sclerosis | 5.19e-05 | 17 | 128 | 3 | cv:C0002736 | |
| Disease | carcinoma (implicated_via_orthology) | 1.75e-04 | 64 | 128 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | cardiovascular disease | 1.78e-04 | 457 | 128 | 9 | EFO_0000319 | |
| Disease | colorectal cancer (is_implicated_in) | 1.89e-04 | 121 | 128 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | cleft lip | 2.49e-04 | 284 | 128 | 7 | EFO_0003959 | |
| Disease | Mental Retardation, X-Linked 1 | 3.61e-04 | 32 | 128 | 3 | C2931498 | |
| Disease | Glycosuria | 3.87e-04 | 7 | 128 | 2 | HP_0003076 | |
| Disease | plasma betaine measurement | 4.32e-04 | 34 | 128 | 3 | EFO_0007787 | |
| Disease | resting heart rate | 4.93e-04 | 149 | 128 | 5 | EFO_0004351 | |
| Disease | smoking cessation | 5.59e-04 | 325 | 128 | 7 | EFO_0004319 | |
| Disease | unipolar depression, bipolar disorder | 6.08e-04 | 156 | 128 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | reticulocyte count | ARHGAP42 KLHL10 ATR USP9X INSR HECTD4 EYA2 ITGAD BAZ1A NFKB1 DMRTA1 EIF2AK2 ZC3HAV1 | 6.32e-04 | 1045 | 128 | 13 | EFO_0007986 |
| Disease | reticulocyte measurement | ARHGAP42 KLHL10 ATR USP9X INSR HECTD4 EYA2 ITGAD BAZ1A NFKB1 DMRTA1 EIF2AK2 ZC3HAV1 | 6.78e-04 | 1053 | 128 | 13 | EFO_0010700 |
| Disease | clinical treatment | 7.53e-04 | 41 | 128 | 3 | EFO_0007056 | |
| Disease | Short Stature, CTCAE | 8.21e-04 | 10 | 128 | 2 | C2919142 | |
| Disease | Short stature | 8.21e-04 | 10 | 128 | 2 | C0349588 | |
| Disease | Diuretic use measurement | 8.71e-04 | 169 | 128 | 5 | EFO_0009928 | |
| Disease | mean arterial pressure, alcohol drinking | 8.91e-04 | 98 | 128 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | neurotic disorder | 9.97e-04 | 101 | 128 | 4 | EFO_0004257 | |
| Disease | gastroesophageal reflux disease | 9.97e-04 | 101 | 128 | 4 | EFO_0003948 | |
| Disease | Colorectal Carcinoma | 9.98e-04 | 702 | 128 | 10 | C0009402 | |
| Disease | endometrial carcinoma, endometriosis | 1.00e-03 | 11 | 128 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | Antihypertensive use measurement | 1.08e-03 | 265 | 128 | 6 | EFO_0009927 | |
| Disease | complex trait | 1.21e-03 | 271 | 128 | 6 | EFO_0010578 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.27e-03 | 49 | 128 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.41e-03 | 13 | 128 | 2 | C3501611 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.41e-03 | 13 | 128 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.43e-03 | 51 | 128 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Prostatic Neoplasms | 1.50e-03 | 616 | 128 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.50e-03 | 616 | 128 | 9 | C0376358 | |
| Disease | mean arterial pressure | 1.54e-03 | 499 | 128 | 8 | EFO_0006340 | |
| Disease | Beta blocking agent use measurement | 1.56e-03 | 114 | 128 | 4 | EFO_0009929 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.61e-03 | 194 | 128 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | left ventricular diastolic function measurement | 1.68e-03 | 54 | 128 | 3 | EFO_0008204 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 1.68e-03 | 54 | 128 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | intelligence, self reported educational attainment | 1.72e-03 | 117 | 128 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.77e-03 | 118 | 128 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | eosinophil count | CPA4 MON2 LIMA1 NAGK ATR HECTD4 RHBDD2 XPNPEP1 HIVEP3 NFKB1 CDYL2 TET3 MYO16 BAHCC1 ZC3HAV1 | 2.03e-03 | 1488 | 128 | 15 | EFO_0004842 |
| Disease | cortical surface area measurement | CPA4 MON2 TANC2 DPP4 MYCBP2 FAT3 FNBP1L MED13L NFKB1 ROBO2 DMRTA1 PRKCZ DCLK1 MYO16 | 2.14e-03 | 1345 | 128 | 14 | EFO_0010736 |
| Disease | Malignant Neoplasms | 2.38e-03 | 128 | 128 | 4 | C0006826 | |
| Disease | systolic blood pressure, alcohol drinking | 2.38e-03 | 128 | 128 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | response to opioid | 2.39e-03 | 61 | 128 | 3 | EFO_0008541 | |
| Disease | Benign neoplasm of stomach | 2.43e-03 | 17 | 128 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.43e-03 | 17 | 128 | 2 | C0496905 | |
| Disease | cyclic adenosine monophosphate measurement | 2.43e-03 | 17 | 128 | 2 | EFO_0010473 | |
| Disease | Lipidemias | 2.43e-03 | 17 | 128 | 2 | C1706412 | |
| Disease | Carcinoma in situ of stomach | 2.43e-03 | 17 | 128 | 2 | C0154060 | |
| Disease | Hyperlipidemia | 2.43e-03 | 17 | 128 | 2 | C0020473 | |
| Disease | irritable bowel syndrome | 2.59e-03 | 131 | 128 | 4 | EFO_0000555 | |
| Disease | brain measurement, neuroimaging measurement | 2.81e-03 | 550 | 128 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | pulse pressure measurement | ARHGAP42 CWF19L2 FAT3 INSR FHOD3 MED13L ZNF831 YES1 CCDC141 HIVEP3 SUPT6H CDYL2 SORCS3 HYDIN | 2.92e-03 | 1392 | 128 | 14 | EFO_0005763 |
| Disease | event free survival time, urinary bladder cancer | 3.04e-03 | 19 | 128 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 3.04e-03 | 19 | 128 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | cortical thickness | CPA4 MON2 DPP4 MYCBP2 FAT3 FNBP1L BAZ1A NFKB1 ROBO2 DMRTA1 PRKCZ MYO16 | 3.36e-03 | 1113 | 128 | 12 | EFO_0004840 |
| Disease | breast size | 3.39e-03 | 69 | 128 | 3 | EFO_0004884 | |
| Disease | dentures | 3.53e-03 | 70 | 128 | 3 | EFO_0010078 | |
| Disease | dental caries, dentures | 3.53e-03 | 70 | 128 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | allergic disease, age at onset | 3.68e-03 | 71 | 128 | 3 | EFO_0004847, MONDO_0005271 | |
| Disease | Infiltrating duct carcinoma of female breast | 3.71e-03 | 21 | 128 | 2 | C3165106 | |
| Disease | Stomach Carcinoma | 3.71e-03 | 21 | 128 | 2 | C0699791 | |
| Disease | cytokine measurement | 4.06e-03 | 461 | 128 | 7 | EFO_0004873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSQESSLRKTDSRGY | 101 | Q96P26 | |
| DTERSSTYRSKGFDV | 131 | Q9Y5Z0 | |
| RQKDTVSRSEAAYGT | 711 | Q9P281 | |
| FSKYSEAAELRSTAS | 681 | Q9Y2D5 | |
| YGATEEDLITSASKT | 416 | Q96P56 | |
| ADGKVYVTAESRFST | 226 | P42684 | |
| SRVTAGKDSYLALVD | 671 | Q96Q42 | |
| TRGSIYAGDVSSSVK | 561 | O94910 | |
| TDGSTICKVSYASLA | 466 | Q3SY69 | |
| SAIKSDTSGDYEITL | 301 | P12429 | |
| VRSTETVDSGYRSFK | 261 | Q9Y2T1 | |
| KERAEQGASLATSYS | 1111 | Q5JTC6 | |
| TETSSRYARKISGTT | 341 | Q9UDT6 | |
| TVGKDGTRDYTEIDS | 1411 | Q8TDJ6 | |
| IYERSRSSDGKSSSQ | 256 | P20930 | |
| SRSASRKTYDKEQSG | 2186 | P20930 | |
| VASSRSSVLKDSEYG | 1626 | Q9UPY3 | |
| DAYSTEDVTVSGRKF | 616 | Q96NY7 | |
| STSKESYITDDIGIS | 231 | Q86YH6 | |
| TIYSSEEDGLSKTSS | 1146 | Q96BY7 | |
| DASDSGRSYKTVLDR | 1101 | Q9NRL2 | |
| SGSVTSENVSRDYKA | 71 | Q13613 | |
| SYLITTDAAGSIATA | 101 | Q9UJ70 | |
| ALSRYGAATFTRTEK | 1266 | P20742 | |
| SGAERYLTISSLQSE | 91 | A0A075B6H9 | |
| SLEQKDLVGYSSTRA | 581 | P56975 | |
| GEALSTYEASRDTKA | 4226 | Q8WXI7 | |
| KSEDTTSLSYTATGL | 896 | P43146 | |
| IAKRVTYDSDATSSA | 51 | O15243 | |
| SYLTGKRISEACSLA | 1336 | P52948 | |
| KSELRSRSSGYSDIS | 646 | Q6ZMT4 | |
| RSSKELSENEVVGSY | 401 | Q6DN14 | |
| AGIDSSLEVSSSRKY | 511 | Q71F56 | |
| SLSLARTKTRSYGST | 41 | Q8IV50 | |
| SRSASGRKISENSYS | 216 | Q9UHB6 | |
| ESSAYRISASARGKE | 41 | Q96FI4 | |
| SGANEYIASTDTLKT | 826 | Q96S38 | |
| NTKLSGSYEEISGSR | 1356 | Q9Y6X6 | |
| TLKLSYVSTASGFED | 666 | P59045 | |
| DVRNTYSSLEGKVSE | 351 | Q13201 | |
| KRSRSLSESYELSSD | 101 | Q6DN90 | |
| AITSTNKYTERDASG | 476 | O15075 | |
| SGSSYARSSVVTAVK | 976 | Q86VP6 | |
| SSVYGLDLSIKRDSS | 4296 | Q9Y6V0 | |
| LYLTTISATDEDSGK | 486 | Q9HC56 | |
| SKSVLAALYSSEGSV | 711 | O00408 | |
| ESRESDLVKYGNSSR | 301 | Q2TBE0 | |
| GNSSRDRYATTDTAK | 311 | Q2TBE0 | |
| YSLESTDVKSLAAGV | 701 | Q9H706 | |
| SYGLRVALSTKGSSV | 796 | Q8TET4 | |
| GTDDATADSRKTYTL | 31 | P27487 | |
| STSYADSVKGRFTIS | 76 | A0A0B4J1X5 | |
| LVTFSDERRTYGAKS | 596 | P06213 | |
| RTDSIGEKLGRYSSS | 1211 | Q7Z3U7 | |
| TSGLSSLKRACYDTV | 161 | Q9Y4D8 | |
| LSSTSAYAVREEAKA | 176 | Q96M63 | |
| KIYAVEGTQSRASSS | 331 | Q13349 | |
| DSSATAYGSTVSKRV | 1151 | P04114 | |
| RYEDGTLSLTSTSDL | 1536 | P04114 | |
| AISSAALSASYKADT | 1841 | P04114 | |
| LTSYFSIESSTKGDV | 3486 | P04114 | |
| KGSVLSREYSGTIAS | 3501 | P04114 | |
| LLSKSASVSGAAYTE | 896 | Q13535 | |
| RDSETTKGSYSLSVR | 171 | P08631 | |
| ARSRESESFYKTGSS | 3226 | Q4G0P3 | |
| EQRSDASATTLYGKV | 421 | Q6JEL2 | |
| LALRDEVKYSASTST | 591 | Q6JEL2 | |
| EDASATVVRVGKYST | 1026 | Q6ZP82 | |
| YRTISDGTISASKQE | 291 | Q5T0N5 | |
| DGSVYTARAVALSDK | 76 | Q14574 | |
| LSEETSVKSDYLSSG | 166 | P19525 | |
| DTNYGSTVDLLDSKT | 151 | Q9NZC4 | |
| RLAAKALASVSGTEY | 336 | Q9UI42 | |
| FSEEYTGSSLKTVER | 301 | Q9NXW2 | |
| SSYLSSKDSITCGRL | 481 | Q5VZB9 | |
| DSSSNEKLTYRITSG | 1176 | Q8TDW7 | |
| SDLYSEIGAITRSAK | 1141 | Q2V2M9 | |
| RKLSSSRTYSSGDLL | 266 | Q9NP62 | |
| GYTDAKRTRVASSSQ | 221 | Q8IX06 | |
| SERSVSERSLSAYAK | 2176 | Q5VT06 | |
| INTASDGKLYVSSES | 176 | P00519 | |
| SGSGSLRTSEKRSLY | 491 | Q92796 | |
| KSLTGLSDSVSQYSD | 596 | Q9NT22 | |
| IGEALLSATEYAKST | 2201 | Q8NDH2 | |
| FYSLLGVSKTASSRE | 36 | Q8IXB1 | |
| AIRAKELVDYSSGAS | 596 | D6RIA3 | |
| KRRLSSSESEESYLS | 1241 | Q96T23 | |
| FKADSLVEGTSSRYS | 71 | Q8N1G2 | |
| TSAELRYSVGSLVDS | 551 | O75334 | |
| STGTALSKYRSRSAD | 206 | Q96CV9 | |
| LTGTFASRYGKDTTT | 286 | O00167 | |
| ASRYGKDTTTSVRIG | 291 | O00167 | |
| TTKVFLVGDYSSSAE | 91 | P08247 | |
| YFAKSAEITGVRSET | 11 | O96033 | |
| EQSESETAGSTKYRL | 1851 | Q93008 | |
| IRKGSSATDSSKYED | 336 | Q96N64 | |
| KGTSYTSLASLEALA | 416 | A5PKW4 | |
| SSLRSISAAEGNKSY | 736 | A6NI28 | |
| SSILISSDEGATYQK | 276 | Q9UPU3 | |
| ASQSLTDIAKYSIGR | 111 | O14494 | |
| TVSNIESFYSRKDTG | 816 | Q7Z333 | |
| ATSSTKLEDLSYLDG | 316 | Q9C0D5 | |
| SRDSGIIATLTSYSE | 176 | Q9HCD6 | |
| LAYTSSSDESEDGRK | 21 | Q9UKZ4 | |
| SSTEERRLNYGGKST | 471 | Q02383 | |
| AIYSDSSSLVTDLKG | 666 | O75592 | |
| SADQLYLETTGKSRT | 196 | Q8TE99 | |
| YSSGKSVARTSLQAE | 3366 | Q9P2P6 | |
| GTDAVIYLKALSSES | 351 | Q15120 | |
| LTYQVSESDSSGETK | 246 | P11831 | |
| DSSCSRYTLKADGTQ | 421 | Q8IZF2 | |
| SGLREYTLTSALKDS | 186 | Q9Y4X0 | |
| SGGDRATKTVSYRTT | 126 | Q8N8U2 | |
| KIDTASLGDSTDSYI | 1036 | Q7KZ85 | |
| KGEVSDGYSVSRSKT | 76 | A0A0K0K1G6 | |
| DTGDTRESSSIYISK | 341 | O60701 | |
| SYAEGVTDRTSNTKL | 316 | Q8NHY6 | |
| AVSSGSSTALLYSKR | 366 | O15164 | |
| GRYTATLDADTKQSS | 81 | A0A0B4J240 | |
| SGAQYKDGTTDVTRT | 416 | Q9NQW7 | |
| KSSRESSEARKGFSY | 101 | P47985 | |
| GDKTTRSSSQYIESF | 246 | Q5JTV8 | |
| RKASTASDVYSFGIL | 196 | Q9Y572 | |
| ATSILSYLSDSDLRG | 376 | Q96MK2 | |
| DKYLGAATSLTVSED | 231 | P31639 | |
| RSGVGLSSYLSTEKD | 486 | Q9BW04 | |
| AGLRSDYSSTIGSDK | 231 | Q7RTY8 | |
| SERKIEFDSASGTYT | 466 | P04844 | |
| AGISSTSTRDLYATV | 151 | A6NJ88 | |
| ISVFKYVSGSSAERR | 226 | Q6NTF9 | |
| YNVKSRLSDVSSGEL | 81 | P20061 | |
| LTYTDAGEVTKADLS | 331 | Q2MV58 | |
| TETRSKSFDYGSLSL | 1006 | Q5T1R4 | |
| TESGATISKNYDLSD | 506 | Q9HCK4 | |
| VAEAVSSYGALSTRL | 206 | O43151 | |
| IRSEGTTSTSYKSLA | 446 | Q9C0B5 | |
| SSRESTEARKGFSYL | 111 | P0C7P4 | |
| AVTTRKGTGLLSSDY | 396 | Q7Z2W4 | |
| LRKCESTDSGYLSRS | 336 | Q5JPB2 | |
| DKSSGRSTLYIAASQ | 86 | A0A0B4J279 | |
| ESETTKGAYSLSIRD | 186 | P07947 | |
| RKFGDDYQVVTTSSS | 6 | P48549 | |
| SEETDGIAYISSSRK | 206 | Q05513 | |
| TLATIKGDEYTFTSS | 1571 | Q13402 | |
| VTLTYATGTKEESAG | 481 | P19838 |